-------------------------------------------------------------------------------
SEC 1745  (02-02)  Potential  persons  who are to respond to the  collection  of
information  contained in this form are not required to respond  unless the form
displays a currently valid OMB control number.
-------------------------------------------------------------------------------

                                                                    OMB APPROVAL
                                                           OMB Number: 3235-0145
                                                      Expires: December 31, 2005
                                                        Estimated average burden
                                                      hours per response. . . 11



                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  SCHEDULE 13G

                    Under the Securities Exchange Act of 1934
                               (Amendment No. 1)*



                            Anika Therapeutics, Inc.
                                (Name of Issuer)


                                  Common Stock
                         (Title of Class of Securities)


                                    035255108
                                 (CUSIP Number)


                                 April 30, 2003
             (Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[ X ] Rule 13d-1(b)
[   ] Rule 13d-1(c)
[   ] Rule 13d-1(d)



*The  remainder of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for any  subsequent  amendment  containing  information  which  would  alter the
disclosures provided in a prior cover page.


The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934 ("Act") or otherwise  subject to the liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).




     1. Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
Federated Investors, Inc.


2.  Check the Appropriate Box if a Member of a Group (See Instructions)


(a)

(b)


3. SEC Use Only


4. Citizenship or Place of Organization
      Pennsylvania


Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5. Sole Voting Power  1,074,870


6. Shared Voting Power

7. Sole Dispositive Power  1,074,870

8. Shared Dispositive Power

9. Aggregate Amount Beneficially Owned by Each Reporting Person  1,074,870

10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares
    (See Instructions)

11. Percent of Class Represented by Amount in Row (9)  10.8%

12. Type of Reporting Person (See Instructions) HC




     1. Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).

Voting Shares Irrevocable Trust


2.  Check the Appropriate Box if a Member of a Group (See Instructions)


(a)

(b)


3. SEC Use Only


4. Citizenship or Place of Organization
      Pennsylvania


Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5. Sole Voting Power  1,074,870


6. Shared Voting Power


7. Sole Dispositive Power  1,074,870


8. Shared Dispositive Power


9. Aggregate Amount Beneficially Owned by Each Reporting Person  1,074,870


10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares
    (See Instructions)

11. Percent of Class Represented by Amount in Row (9)  10.8%


12. Type of Reporting Person (See Instructions) OO



     1. Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).

John F. Donahue


2.  Check the Appropriate Box if a Member of a Group (See Instructions)


(a)

(b)


3. SEC Use Only


4. Citizenship or Place of Organization
      United States


Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5. Sole Voting Power


6. Shared Voting Power  1,074,870


7. Sole Dispositive Power


8. Shared Dispositive Power  1,074,870


9. Aggregate Amount Beneficially Owned by Each Reporting Person  1,074,870


10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares
    (See Instructions)

11. Percent of Class Represented by Amount in Row (9)  10.8%


12. Type of Reporting Person (See Instructions) IN



     1. Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).

Rhodora J. Donahue


2.  Check the Appropriate Box if a Member of a Group (See Instructions)


(a)

(b)


3. SEC Use Only


4. Citizenship or Place of Organization
      United States


Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5. Sole Voting Power


6. Shared Voting Power  1,074,870


7. Sole Dispositive Power


8. Shared Dispositive Power  1,074,870


9. Aggregate Amount Beneficially Owned by Each Reporting Person  1,074,870


10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares
    (See Instructions)

11. Percent of Class Represented by Amount in Row (9) 10.8%

12. Type of Reporting Person (See Instructions) IN



     1. Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
J. Christopher Donahue


2.  Check the Appropriate Box if a Member of a Group (See Instructions)


(a)

(b)


3. SEC Use Only


4. Citizenship or Place of Organization
      United States


Number of
Shares
Beneficially
Owned by
Each Reporting
Person With
5. Sole Voting Power


6. Shared Voting Power  1,074,870


7. Sole Dispositive Power


8. Shared Dispositive Power  1,074,870


9. Aggregate Amount Beneficially Owned by Each Reporting Person  1,074,870


10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares
    (See Instructions)

11. Percent of Class Represented by Amount in Row (9) 10.8%


12. Type of Reporting Person (See Instructions) IN


INSTRUCTIONS FOR SCHEDULE 13G

Instructions for Cover Page

(l)  Names and I.R.S.  Identification  Numbers of Reporting  Persons-Furnish the
     full legal name of each  person  for whom the  report is  filed-i.e.,  each
     person  required  to sign the  schedule  itself-including  each member of a
     group. Do not include the name of a person required to be identified in the
     report  but who is not a  reporting  person.  Reporting  persons  that  are
     entities are also requested to furnish their I.R.S. identification numbers,
     although  disclosure  of such  numbers is  voluntary,  not  mandatory  (see
     "SPECIAL INSTRUCTIONS FOR COMPLYING WITH SCHEDULE 13G" below).

(2)  If any of the shares beneficially owned by a reporting person are held as a
     member of a group and that membership is expressly  affirmed,  please check
     row  2(a).  If the  reporting  person  disclaims  membership  in a group or
     describes  a  relationship  with  other  persons  but does not  affirm  the
     existence  of a group,  please  check row 2(b) [unless it is a joint filing
     pursuant to Rule  13d1(k)(1) in which case it may not be necessary to check
     row 2(b)].

(3)  The third row is for SEC internal use; please leave blank.

(4)  Citizenship  or  Place of  Organization-Furnish  citizenship  if the  named
     reporting  person  is  a  natural  person.  Otherwise,   furnish  place  of
     organization.

(5)-(9), (11) Aggregate  Amount  Beneficially  Owned By Each  Reporting  Person,
     Etc.-Rows  (5)  through  (9)  inclusive,  and (11) are to be  completed  in
     accordance  with the provisions of Item 4 of Schedule 13G. All  percentages
     are to be rounded off to the nearest tenth (one place after decimal point).

(10) Check if the aggregate  amount  reported as  beneficially  owned in row (9)
     does not include  shares as to which  beneficial  ownership  is  disclaimed
     pursuant to Rule 13d-4 (17 CFR 240.13d-4] under the Securities Exchange Act
     of 1934.

(12) Type of Reporting  Person-Please classify each "reporting person" according
     to the  following  breakdown  (see  Item 3 of  Schedule  13G) and place the
     appropriate symbol on the form:

Category Symbol
Broker Dealer  BD
Bank  BK
Insurance Company  IC
Investment Company  IV
Investment Adviser  IA
Employee Benefit Plan, Pension Fund, or Endowment Fund  EP
Parent Holding Company/Control Person  HC
Savings Association  SA
Church Plan  CP
Corporation  CO
Partnership  PN
Individual  IN
Other  OO


Notes: Attach as many copies of the second part of the cover page as are needed,
one reporting person per page.

Filing persons may, in order to avoid unnecessary  duplication,  answer items on
the schedules  (Schedule 13D, 13G or 14D1) by appropriate cross references to an
item or items on the cover  page(s).  This  approach  may only be used where the
cover page item or items  provide all the  disclosure  required by the  schedule
item. Moreover, such a use of a cover page item will result in the item becoming
a part of the schedule and accordingly  being considered as "filed" for purposes
of  Section  18 of the  Securities  Exchange  Act or  otherwise  subject  to the
liabilities of that section of the Act.


Reporting persons may comply with their cover page filing requirements by filing
either  completed  copies  of the blank  forms  available  from the  Commission,
printed or typed  facsimiles,  or  computer  printed  facsimiles,  provided  the
documents  filed  have  identical   formats  to  the  forms  prescribed  in  the
Commission's  regulations and meet existing  Securities Exchange Act rules as to
such matters as clarity and size (Securities Exchange Act Rule 12b-12).


SPECIAL INSTRUCTIONS FOR COMPLYING WITH SCHEDULE 13G

Under Sections 13(d),  13(g), and 23 of the Securities  Exchange Act of 1934 and
the rules and  regulations  thereunder,  the Commission is authorized to solicit
the  information  required to be supplied by this  schedule by certain  security
holders of certain issuers.

Disclosure of the  information  specified in this schedule is mandatory,  except
for  I.R.S.  identification  numbers,  disclosure  of  which is  voluntary.  The
information  will be used for the primary  purpose of determining and disclosing
the holdings of certain  beneficial  owners of certain equity  securities.  This
statement will be made a matter of public  record.  Therefore,  any  information
given will be available for inspection by any member of the public.

Because of the public nature of the information, the Commission can use it for a
variety of purposes,  including  referral to other  governmental  authorities or
securities  self-regulatory  organizations  for  investigatory  purposes  or  in
connection with litigation involving the Federal securities laws or other civil,
criminal or regulatory statutes or provisions. I.R.S. identification numbers, if
furnished,  will assist the  Commission  in  identifying  security  holders and,
therefore,   in  promptly  processing  statements  of  beneficial  ownership  of
securities.

Failure to disclose  the  information  requested  by this  schedule,  except for
I.R.S.  identification  numbers,  may result in civil or criminal action against
the persons  involved  for  violation of the Federal  securities  laws and rules
promulgated thereunder.

GENERAL INSTRUCTIONS

A.   Statements  filed  pursuant to Rule  13d-1(b)  containing  the  information
     required  by this  schedule  shall be filed  not  later  than  February  14
     following  the calendar  year  covered by the  statement or within the time
     specified in Rules  13d-1(b)(2) and 13d2(c).  Statements  filed pursuant to
     Rule 13d-1(c) shall be filed within the time  specified in Rules  13d-1(c),
     13d-2(b) and 13d-2(d).  Statements filed pursuant to Rule 13d-1(d) shall be
     filed not later than February 14 following the calendar year covered by the
     statement pursuant to Rules 13d-1(d) and 13d-2(b).

B.   Information  contained  in a form  which is  required  to be filed by rules
     under section  13(f) (15 U.S.C.  78m(f)) for the same calendar year as that
     covered by a statement on this schedule may be incorporated by reference in
     response  to any of the  items of this  schedule.  If such  information  is
     incorporated by reference in this schedule, copies of the relevant pages of
     such form shall be filed as an exhibit to this schedule.

C.   The item  numbers and  captions of the items shall be included but the text
     of the  items  is to be  omitted.  The  answers  to the  items  shall be so
     prepared as to indicate clearly the coverage of the items without referring
     to the text of the items.  Answer every item. If an item is inapplicable or
     the answer is in the negative, so state.


Item 1.


(a) Name of Issuer
Anika Therapeutics, Inc.

(b) Address of Issuer's Principal Executive Offices
160 New Boston Street, Woburn, MA 01801

Item 2.

(a) Name of Person Filing SEE ROW 1 OF COVER PAGES


(b) Address of Principal Business Office or, if none, Residence
Federated Investors Tower, Pittsburgh, PA 15222-3779

(c) Citizenship SEE ROWS 1 AND 4 OF COVER PAGES


(d) Title of Class of Securities
Common stock

(e) CUSIP Number 035255108



Item  3.  If  this  statement  is  filed  pursuant  to   ss.ss.240.13d-1(b)   or
240.13d-2(b) or (c), check whether the person filing is a:

(a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c) [ ] Insurance  company as defined in section  3(a)(19) of the Act (15 U.S.C.
78c).

(d) [ ] Investment  company registered under section 8 of the Investment Company
Act of 1940 (15 U.S.C 80a-8).

(e) [ ] An investment adviser in accordance with ss.240.13d-1(b)(1)(ii)(E);

(f)  [ ]  An  employee  benefit  plan  or  endowment  fund  in  accordance  with
ss.240.13d-1(b)(1)(ii)(F);

(g) [ X ] A parent  holding  company or control  person in  accordance  with ss.
240.13d-1(b)(1)(ii)(G);

(h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit
Insurance Act (12 U.S.C. 1813);

(i) [ ] A church  plan that is excluded  from the  definition  of an  investment
company under section 3(c)(14) of the Investment  Company Act of 1940 (15 U.S.C.
80a-3);

(j) [ ] Group, in accordance with ss.240.13d-1(b)(1)(ii)(J).




Item 4. Ownership.

Provide the following  information regarding the aggregate number and percentage
of the class of securities of the issuer identified in Item 1.

A.    Federated Investors, Inc. (See Footnote 1, next page)
 (a) Amount beneficially owned: 1,074,870

 (b) Percent of class: 10.8%

 (c) Number of shares as to which the person has:

 (i) Sole power to vote or to direct the vote 1,074,870

 (ii) Shared power to vote or to direct the vote -0-

 (iii) Sole power to dispose or to direct the disposition of 1,074,870

 (iv) Shared power to dispose or to direct the disposition of -0-

B.    Voting Shares Irrevocable Trust
 (a) Amount beneficially owned: 1,074,870

 (b) Percent of class: 10.8%

 (c) Number of shares as to which the person has:

 (i) Sole power to vote or to direct the vote 1,074,870

 (ii) Shared power to vote or to direct the vote -0-

 (iii) Sole power to dispose or to direct the disposition of 1,074,870

 (iv) Shared power to dispose or to direct the disposition of -0-

C.    John F. Donahue
 (a) Amount beneficially owned: 1,074,870

 (b) Percent of class: 10.8%

 (c) Number of shares as to which the person has:

 (i) Sole power to vote or to direct the vote -0-

 (ii) Shared power to vote or to direct the vote 1,074,870

 (iii) Sole power to dispose or to direct the disposition of -0-

 (iv) Shared power to dispose or to direct the disposition of 1,074,870

D.    Rhodora J. Donahue
 (a) Amount beneficially owned: 1,074,870

 (b) Percent of class: 10.8%

 (c) Number of shares as to which the person has:

 (i) Sole power to vote or to direct the vote -0-

 (ii) Shared power to vote or to direct the vote 1,074,870

 (iii) Sole power to dispose or to direct the disposition of -0-

 (iv) Shared power to dispose or to direct the disposition of 1,074,870

E.    J. Christopher Donahue
 (a) Amount beneficially owned: 1,074,870

 (b) Percent of class: 10.8%

 (c) Number of shares as to which the person has:

 (i) Sole power to vote or to direct the vote -0-

 (ii) Shared power to vote or to direct the vote 1,074,870

 (iii) Sole power to dispose or to direct the disposition of -0-

 (iv) Shared power to dispose or to direct the disposition of 1,074,870


Instruction.  For computations  regarding  securities which represent a right to
acquire an underlying security see ss.240.13d3(d)(1).



Item 5. Ownership of Five Percent or Less of a Class

If this  statement  is being filed to report the fact that as of the date hereof
the  reporting  person has ceased to be the  beneficial  owner of more than five
percent of the class of securities, check the following [ ].

Instruction: Dissolution of a group requires a response to this item.

Item 6. Ownership of More than Five Percent on Behalf of Another Person.
NOT APPLICABLE

Item 7. Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on By the Parent Holding Company or Control Person.
SEE EXHIBIT "1" ATTACHED

Item 8. Identification and Classification of Members of the Group
NOT APPLICABLE


Item 9. Notice of Dissolution of Group
NOT APPLICABLE


Item 10. Certification

(a)  The  following  certification  shall be included if the  statement is filed
     pursuant to ss.240.13d-1(b):

By signing below I certify  that,  to the best of my knowledge  and belief,  the
securities  referred to above were acquired and are held in the ordinary  course
of business  and were not  acquired  and are not held for the purpose of or with
the  effect  of  changing  or  influencing  the  control  of the  issuer  of the
securities  and were not  acquired and are not held in  connection  with or as a
participant in any transaction having that purpose or effect.

(b)  The  following  certification  shall be included if the  statement is filed
     pursuant to ss.240.13d-1(c):

By signing below I certify  that,  to the best of my knowledge  and belief,  the
securities  referred to above were not acquired and are not held for the purpose
of or with the effect of  changing or  influencing  the control of the issuer of
the securities and were not acquired and are not held in connection with or as a
participant in any transaction having that purpose or effect.

SIGNATURE

After  reasonable  inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.


Date:  May 8, 2003
By: /s/J. Christopher Donahue
Name/Title:  J. Christopher Donahue, as President of Federated Investors, Inc.

By: /s/John F. Donahue
Name/Title:  John F. Donahue, individually and as Trustee of Voting Shares
Irrevocable Trust, by J. Christopher Donahue, as attorney-in-fact

By: /s/Rhodora J. Donahue
Name/Title:  Rhodora J. Donahue, individually and as Trustee of Voting Shares
Irrevocable Trust, by J. Christopher Donahue, as attorney-in-fact

By: /s/J. Christopher Donahue
Name/Title:  J. Christopher Donahue, individually and as Trustee of Voting
Shares Irrevocable Trust

Reference  is herein  made to  Exhibit  3,  Power of  Attorney,  filed  with the
Securities and Exchange Commission on February 14,2003.

The  original  statement  shall be signed by each  person  on whose  behalf  the
statement is filed or his authorized representative.  If the statement is signed
on behalf of a person by his authorized  representative  other than an executive
officer  or   general   partner  of  the   filing   person,   evidence   of  the
representative's  authority to sign on behalf of such person shall be filed with
the  statement,  provided,  however,  that a power of attorney  for this purpose
which is already on file with the Commission may be  incorporated  by reference.
The name and any title of each person who signs the statement  shall be typed or
printed beneath his signature.

NOTE:  Schedules  filed in paper format shall include a signed original and five
copies of the  schedule,  including  all exhibits.  See  ss.240.13d-7  for other
parties for whom copies are to be sent.

Attention: Intentional misstatements or omissions of fact constitute Federal
criminal violations
(See 18 U.S.C. 1001)

                                   EXHIBIT "1"

                            ITEM 3 CLASSIFICATION OF
                                REPORTING PERSONS
              Identity and Classification of Each Reporting Person




                                       

IDENTITY                                  CLASSIFICATION UNDER ITEM 3

American Skandia Trust                    (d) Investment company registered under
                                          Section 8 of the Investment Company Act of
                                          1940 (15 U.S.C. 80a-8).


Federated Equity Funds                    (d) Investment company registered under
                                          Section 8 of the Investment Company Act of
                                          1940 (15 U.S.C. 80a-8).

Federated Insurance Series                (d) Investment company registered under
                                          Section 8 of the Investment Company Act of
                                          1940 (15 U.S.C. 80a-8).

Federated Investment Management           (e) Investment Adviser registered under
      Company                             section 203 of the Investment Advisers
                                          Act of 1940

Federated Investment Counseling           (e) Investment Adviser registered under section
                                          203 of the Investment Advisers Act of 1940

Federated Global Investment               (e) Investment Adviser registered under
      Management Company                  section 203 of the Investment Advisers
                                          Act of 1940
Federated Investors, Inc.                 (g) Parent Holding Company, in accordance with
                                          Section 240.13d-1(b)(ii)(G)

FII Holdings, Inc.                        (g) Parent Holding Company, in accordance with
                                          Section 240.13d-1(b)(ii)(G)

Voting Shares Irrevocable Trust           (g) Parent Holding Company, in accordance with
                                          Section 240.13d-1(b)(ii)(G)

John F. Donahue                           (g) Parent Holding Company, in accordance with
                                          Section 240.13d-1(b)(ii)(G)

Rhodora J. Donahue                        (g) Parent Holding Company, in accordance with
                                          Section 240.13d-1(b)(ii)(G)

J. Christopher Donahue                    (g) Parent Holding Company, in accordance with
                                          Section 240.13d-1(b)(ii)(G)



Federated Investors,  Inc. (the "Parent") is filing this Schedule 13G because it
is the  parent  holding  company of  Federated  Investment  Management  Company,
Federated  Investment  Counseling,  and Federated Global  Investment  Management
Corp.  (the  "Investment  Advisers"),   which  act  as  investment  advisers  to
registered  investment companies and separate accounts that own shares of common
stock in Anika Therapeutics,  Inc. (the "Reported  Securities').  The Investment
Advisers are wholly owned  subsidiaries of FII Holdings,  Inc.,  which is wholly
owned subsidiary of Federated  Investors,  Inc., the Parent. All of the Parent's
outstanding  voting stock is held in the Voting  Shares  Irrevocable  Trust (the
"Trust")  for which John F.  Donahue,  Rhodora  J.  Donahue  and J.  Christopher
Donahue act as trustees (collectively, the "Trustees"). The Trustees have joined
in filing this Schedule 13G because of the  collective  voting control that they
exercise over the Parent. In accordance with Rule 13d-4 under the Securities Act
of 1934, as amended,  the Parent,  the Trust,  and each of the Trustees  declare
that this  statement  should not be construed as an admission  that they are the
beneficial  owners of the Reported  Securities,  and the Parent,  the Trust, and
each of the Trustees  expressly  disclaim  beneficial  ownership of the Reported
Securities


                                   EXHIBIT "2"

                          AGREEMENT FOR JOINT FILING OF

                                  SCHEDULE 13G

     The  following  parties  hereby  agree to file  jointly  the  statement  on
Schedule  13G to which this  Agreement is attached  and any  amendments  thereto
which may be deemed necessary  pursuant to Regulation 13D-G under the Securities
Exchange Act of 1934:

1.   Federated  Investors,  Inc.  as parent  holding  company of the  investment
     advisers to  registered  investment  companies  that  beneficially  own the
     securities.

Voting Shares Irrevocable Trust, as holder of all the voting shares of
Federated Investors, Inc.

John F. Donahue, individually and as Trustee

Rhodora J. Donahue, individually and as Trustee

J. Christopher Donahue, individually and as Trustee

     It is understood  and agreed that each of the parties hereto is responsible
for the timely filing of such statement and any amendments thereto,  and for the
completeness  and accuracy of the  information  concerning  such party contained
therein,  but such party is not responsible for the  completeness or accuracy of
information  concerning  the other parties unless such party knows or has reason
to believe that such information is incomplete or inaccurate.

     It is understood and agreed that the joint filing of Schedule 13G shall not
be construed as an admission that the reporting  persons named herein constitute
a group for purposes of Regulation 13D-G of the Securities Exchange Act of 1934,
nor is a joint venture for purposes of the Investment Company Act of 1940.

Date:       May 8, 2003

By:   /s/J. Christopher Donahue
Name/Title: J. Christopher Donahue, as President of Federated Investors, Inc.

By:   /s/ J. Christopher Donahue
Name/Title: John F. Donahue, individually and as Trustee of Voting Shares
Irrevocable Trust, by J. Christopher Donahue, as attorney-in-fact.

By:   /s/   Rhodora J. Donahue
Name/Title: Rhodora J. Donahue, individually and as Trustee as Voting Shares
Irrevocable Trust, by J. Christopher Donahue, as attorney-in-fact.

By:   /s/   J. Christopher Donahue
Name/Title: J. Christopher Donahue, individually and as Trustee of Voting Shares
Irrevocable Trust

The number of shares indicated represent shares beneficially owned by registered
investment  companies and separate accounts advised by subsidiaries of Federated
Investors,  Inc. that have been  delegated the power to direct  investments  and
power to vote the securities by the registered  investment  companies'  board of
trustees or  directors  and by the  separate  accounts'  principals.  All of the
voting  securities  of Federated  Investors,  Inc. are held in the Voting Shares
Irrevocable Trust ("Trust"),  the trustees of which are John F. Donahue, Rhodora
J. Donahue,  and J. Christopher  Donahue  ("Trustees').  In accordance with Rule
13d-4  under the 1934 Act,  the  Trust,  Trustees,  and parent  holding  company
declare  that  the  filing  of this  statement  should  not be  construed  as an
admission that any of the investment  advisers,  parent holding company,  Trust,
and Trustees are  beneficial  owners (for the purposes of Sections  13(d) and/or
13(g)  of the  Act) of any  securities  covered  by  this  statement,  and  such
advisers,  parent holding company,  Trust, and Trustees  expressly disclaim that
they are the beneficial owners such securities.